Evidence map›Paper›PMID 42799247›Full record

ArticleFASEB bioAdvances2026

A Simple Temperature-Controlled Method for Preserving Viability in Human Pluripotent Stem Cell-Derived Retinal Organoids During Shipment.

Karen Cusato, Matthew J Tarchick, Michael Ha, Jessica R Onyak, Aimee C Saunders, Joseph A Brzezinski, Jordan M Renna, M Natalia Vergara

Abstract read
In one paragraph

Article in FASEB bioAdvances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karen CusatoDepartment of Ophthalmology, CellSight Ocular Stem Cell and Regeneration Research Program, Sue Anschutz-Rodgers Eye Center University of Colorado Anschutz School of Medicine Aurora Colorado USA.
Matthew J TarchickDepartment of Biology The University of Akron Akron Ohio USA.
Michael HaDepartment of Ophthalmology, CellSight Ocular Stem Cell and Regeneration Research Program, Sue Anschutz-Rodgers Eye Center University of Colorado Anschutz School of Medicine Aurora Colorado USA.
Jessica R OnyakDepartment of Biology The University of Akron Akron Ohio USA.
Aimee C SaundersDepartment of Biology The University of Akron Akron Ohio USA.
Joseph A BrzezinskiDepartment of Ophthalmology, CellSight Ocular Stem Cell and Regeneration Research Program, Sue Anschutz-Rodgers Eye Center University of Colorado Anschutz School of Medicine Aurora Colorado USA.ORCID https://orcid.org/0000-0001-5854-0315
Jordan M RennaDepartment of Biology The University of Akron Akron Ohio USA.ORCID https://orcid.org/0000-0003-3873-239X
M Natalia VergaraDepartment of Ophthalmology, CellSight Ocular Stem Cell and Regeneration Research Program, Sue Anschutz-Rodgers Eye Center University of Colorado Anschutz School of Medicine Aurora Colorado USA.ORCID https://orcid.org/0000-0003-4545-8181

Funding

Novel tools for screening retinal function using improved human retinal organoid modelsR21EY033127 · NEI · UNIVERSITY OF AKRON · PI RENNA, JORDAN MICHAEL, VERGARA, MARIA NATALIA · 2021 to 2022
$433k
NEI NIH HHS R21 EY033127
6 · The paper itself

Abstract

Retinal organoids derived from human induced pluripotent stem cells (hiPSCs) hold significant promise as a tool for advancing our understanding of human retinal development and disease, as well as for the development of therapeutic strategies. However, research utilizing hiPSC-derived retinal organoid models has been constrained by logistical challenges. A notable issue is the increasing need for scientific collaboration, as experiments requiring coordination across multiple institutions often rely on the shipping of live tissues. Transporting retinal organoids over long distances without adequate climate control can lead to tissue degradation, which may interfere with histopathological analyses and impact the results of drug screening assays. Retinal organoids are most often shipped either without temperature regulation or with lithium-ion battery-powered ambient environment systems, which are heavily regulated by standard shipping companies, thus raising costs and introducing further logistical complications. In this study, we developed and evaluated a straightforward, cost-effective, and dependable temperature-controlled technology for shipping retinal organoids that can maintain adequate shipping temperature in colder months and decrease temperature fluctuations during shipment year-round, preserving organoid tissue structure and viability.

Indexed as

retinal organoidshipmenttemperature controlviability

Identifiers

PMID42799247
PMCPMC13614447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.